Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Risankizumab
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Risankizumab Skyrizi
®
(150mg solution for injection in pre-filled syringe or pen)
Skin, Drugs affecting the immune response, 13.05.03
RED
Risankizumab Skyrizi
®
(600mg concentrate for solution for infusion, 360mg solution for injection in cartridge)
Gastro-intestinal system, Cytokine inhibitors, 01.05.03
RED
Risankizumab Skyrizi
®
(150mg solution for injection in pre-filled syringe or pen)
Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
Links found
NICE TA596 Risankizumab for treating moderate to severe plaque psoriasis
NICE TA803 Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
NICE TA803: Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
NICE TA888: Risankizumab for previously treated moderately to severely active Crohn’s disease
NICE TA998: Risankizumab for treating moderately to severely active ulcerative colitis